What's happening internally: AOD 9604 is binding to receptors, initiating lipolysis, and shifting your metabolism toward fat oxidation
Adding too little water creates overly concentrated solutions where small measurement errors translate to large dose variations
You need to support it with appropriate diet and training
In rodent knockout models where beta-3 adrenergic receptors were removed, the lipolytic response to AOD 9604 was eliminated, confirming the receptor-specific mechanism
Clinical Trial Dosing Data AOD-9604 has been evaluated across multiple administration routes and dosing regimens
Specifically, researchers examined the effects of intra-articular injections of AOD9604, both alone and in combination with HA, on cartilage morphology, histopathology, and functional outcomes such as lameness